|
Volumn 62, Issue 3, 2002, Pages 892-900
|
An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-β-D-arabinofuranosylcytosine
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CAMPTOTHECIN;
CYTARABINE;
CYTOTOXIC AGENT;
DNA TOPOISOMERASE INHIBITOR;
ETOPOSIDE;
GROWTH FACTOR;
PHORBOL 13 ACETATE 12 MYRISTATE;
PROTEIN BCL 2;
PROTEIN MCL 1;
STAUROSPORINE;
APOPTOSIS;
ARTICLE;
BURKITT LYMPHOMA;
CANCER CELL CULTURE;
CANCER GROWTH;
CANCER RESISTANCE;
CELL DEATH;
CELL SURVIVAL;
CELL VIABILITY;
CONTROLLED STUDY;
DRUG EFFECT;
GENE AMPLIFICATION;
GENE OVEREXPRESSION;
GROWTH RATE;
HUMAN;
HUMAN CELL;
INCUBATION TIME;
PRIORITY JOURNAL;
SERUM;
ANTIMETABOLITES, ANTINEOPLASTIC;
APOPTOSIS;
BURKITT LYMPHOMA;
CAMPTOTHECIN;
CELL SURVIVAL;
CULTURE MEDIA, SERUM-FREE;
CYTARABINE;
DNA TOPOISOMERASES;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
ENZYME INHIBITORS;
ETOPOSIDE;
HUMANS;
NEOPLASM PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
STAUROSPORINE;
TUMOR CELLS, CULTURED;
|
EID: 0036468529
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (27)
|
References (48)
|